Neoadjuvant Immunotherapy for Liver Cancer: Shrinking Tumors, Growing Responses
Treating seemingly inoperable liver tumors with neoadjuvant immunotherapy may make surgery more feasible.
Category: Awareness Months
Treating seemingly inoperable liver tumors with neoadjuvant immunotherapy may make surgery more feasible.
Changes to sexual health during breast cancer treatment can impact quality of life and treatment adherence—especially in Black women.
Researchers are exploring new combinations of therapy, disrupting iron accumulation, and turning tumors hot in attempts to make ovarian...
Recent advances in the genomics of childhood cancer may help inform potential causes and better treatment strategies.
Former Philadelphia Mayor Michael Nutter received a humanitarian award for his work as a prostate cancer advocate and dedication...
Researchers examined how the molecular features of Hodgkin lymphomas differ between young and older patients.
New research improves physicians' “molecular chess” game against thyroid cancer to overcome resistance to treatments.
Researchers are making progress on genetic classification of sarcoma tumors, the use of T-cell therapy, and nanomedicine delivery.
LGBTQ+ cancer survivors offer lessons learned, and a researcher explains the odds of chronic conditions in LGBTQ+ survivors.
The journey to the first approved TIL therapy began with Steven A. Rosenberg over 30 years ago.